ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CVSG Cvs Group Plc

975.00
14.00 (1.46%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  14.00 1.46% 975.00 974.00 978.00 977.00 950.00 961.00 162,234 16:35:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 608.3M 41.9M 0.5843 16.72 700.64M
Cvs Group Plc is listed in the Veterinary Svcs-animal Specs sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 961p. Over the last year, Cvs shares have traded in a share price range of 905.00p to 2,226.00p.

Cvs currently has 71,712,970 shares in issue. The market capitalisation of Cvs is £700.64 million. Cvs has a price to earnings ratio (PE ratio) of 16.72.

Cvs Share Discussion Threads

Showing 401 to 423 of 975 messages
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older
DateSubjectAuthorDiscuss
30/11/2017
09:24
Still holding CVSG stock bought for 76p, I think that I will give them the benefit of the doubt for the time being........
lomax99
30/11/2017
09:10
Jak - agreed does not look good
gswredland
30/11/2017
08:49
Cant see things getting any better. Priced for perfection. First of three warnings I think...
jak1
30/11/2017
08:29
Uncertainty abounds..
bulltradept
23/11/2017
20:07
The PE is high, but management have a good record of building the business. There is more organic growth by acquisitions in the UK and we're just started in Netherlands. Would this model work in other countries? I like the animal hospital and crematoria fed by the surgeries - maybe add drug distribution?Main question in my mind is whether the % expansion rate can continue.Share price is volatile, which provides opportunities for trading, but the trend is up and I would be a pure holder if it was more consistent.
ewanwhose
23/11/2017
11:00
Consensus PE to 30th June 27.9x. Two years ago it was 22.9x but PEG is only 0.8x, so it constantly grows in to its value. It has been a lovely Buy & Hold.
martinthebrave
23/11/2017
09:52
A well -thought out response.
Thank you.
I still think that as the article states, Microsoft PE was 100 at one point when in its high -growth phase but then retreated as things changed.

Whilst PETS might be a different animal,
CVS at 75 ... surely cannot be compared to Microsoft!

Therefore it is not for me.

hazl
23/11/2017
08:11
hazl: paying for quality?

PETS: latest eps growth 3.34%; forecast eps growth minus 12.27%

CVSG: latest eps growth 43.54%; forecast eps growth 110.72%

PETS is a retailer with veterinary add on

CVSG dedicated veterinary, with additions such as pet crematoria.

The closest company, by sector, is arguably DPH (animal pharma): not cheap either, but again quality.

saucepan
22/11/2017
19:14
Why is this so much higher PE ratio than say Pets at Home?
Both seem to have good fundamentals but isn't 75 a bit rich?

Just curious on passing through the bbs.

hazl
22/11/2017
18:27
AGM next Thursday, usually accompanied by a brief update, expecting this to kick-on accordingly. I have been buying the dips.
lomax99
22/11/2017
18:04
"What is going on?"

Well, no posts since 18 October!

It looks to me like the £14 level is significant level. It has held back momentum since June.

If it breaks again this time, I think it will be time to kick on again.

A very strong move this pm.

saucepan
18/10/2017
21:50
What is going on??
spudleywoo
12/10/2017
17:19
Hi one and all! I have been trying to find a suitable entry point to get in here for a long time. Finally bit the bullet and bought in today. Long term hold that I will add to hopefully. GLA.
martinthebrave
05/10/2017
09:46
Positive little article in Shares magazine this week. Mentions the move into pet insurance, noting it wont see financial benefits in this FY.
wobaguk
29/9/2017
08:08
Another excellent set of results.
lomax99
17/9/2017
10:43
LOL

A NICE ONE TOO PET

ariane
17/9/2017
09:43
Here is one that could not be considered a fleu or a tick!!
lomax99
17/9/2017
06:56
is it not already in our kennel

if not it be likened no doubt to a fleu or tick on a dogs back



PET, GO GET

YER VET

ariane
16/9/2017
20:54
Hi guys, relatively new to board so apologies if repeated. Is anyone aware of a company called VetPartners? Recently acquired our local vets and they have lost a lot of clients due to price hikes. Wondered if these were a threat to CVSG. Thanks in advance
drobinson1991
12/9/2017
08:47
Another useful acquisition:

Equine veterinary group sold to CVS

A Gloucestershire-based veterinary group has been acquired by Norfolk-headquartered counterpart CVS Group.

B&W Equine Veterinary Group was established in 2009 through the merger of established equine practices Bushy Equine Vets and The Willesley Equine Clinic.

The company is said to be largest specialist equine veterinary group in the South West of the UK with a practice based around a multi-disciplinary referral hospital in Breadstone, Gloucestershire. It also has practices in Cardiff, Gloucestershire and Bristol, employing more than 100 staff.

The acquisition is said to be a strategically important deal for CVS, providing it with a presence in the UK equine market. This division has grown rapidly over the last 18 months and now stands at 32 sites.

The group plans to continue to develop and grow the B&W business to optimise its potential.

Simon Innes, chief executive of CVS, said: "The team at B&W bring enormous expertise to the CVS Equine group, and we are thrilled to have them join us, particularly as we are growing so rapidly in our equine division.

"CVS looks forward to working with the B&W team to continue to deliver high levels of expertise and service as we deliver the next phase of growth together."

Momentum Corporate Finance advised the sharehlders of B&W on the sale. Partner Rob Crews said:"We are delighted to have advised the shareholders of B&W on the sale to CVS. The compelling strategic fit between the businesses means that CVS is the right buyer to help B&W continue its recent growth and we believe that it will be a supportive owner in the years to come.

"Following on from the sale of Highcroft Veterinary Group, this is the second leading independent veterinary group sale on which we have successfully advised. With high sales multiples being seen, and significant opportunity for further consolidation in the sector, this is an excellent time for veterinary group owners to consider realising their value."


Hopefully more details on the deal in the next results.....

lomax99
31/7/2017
08:51
Well the market might like to take a look at CVSG's 5 year share price chart, and contemplate the prospects for the sector/CVSG moving forward......
lomax99
31/7/2017
08:50
Anything with in line with expectations is getting punished.
gswredland
31/7/2017
08:46
I think the market just thinks its pedestrian!
chrisgail
Chat Pages: Latest  27  26  25  24  23  22  21  20  19  18  17  16  Older

Your Recent History

Delayed Upgrade Clock